Gout
Eric Gout, Igny FR
Patent application number | Description | Published |
---|---|---|
20080246675 | Field Winding - The invention concerns an inductor comprising a plurality of so-called first conductors ( | 10-09-2008 |
20080314980 | Storage Rack with Automatic Tag Reading Device and Information Processing System Comprising Such a Storage Rack | 12-25-2008 |
20120031971 | STORAGE RACK WITH AUTOMATIC TAG READING DEVICE AND PRODUCT FOR PLACEMENT IN SUCH A STORAGE RACK - A product that has the shape of a rectangular parallelepiped comprises at least one metallic part with at least one narrow edge. The product further comprises an electronic tag having an antenna positioned substantially perpendicular to a narrow edge of said at least one metallic part. A paper label is positioned on at least one of the following sides of the product: (i) a side opposite to a side of the product bearing said electronic tag, and (ii) a side of the product adjacent to a side of the product bearing said electronic tag on one of its small sides. | 02-09-2012 |
20120188039 | FIELD WINDING - The invention concerns an inductor comprising a plurality of so-called first conductors ( | 07-26-2012 |
20140319227 | Inductor - The invention concerns an inductor comprising a plurality of so-called first conductors ( | 10-30-2014 |
Eric Gout, Verrieres-Le-Buisson FR
Patent application number | Description | Published |
---|---|---|
20100271795 | RFID SYSTEM - An antenna assembly (AA) for an RFID system comprises a main winding (WM) that extends over a volume (VI). The antenna assembly (AA) further comprises an auxiliary winding (WA), which is concentrated at one side of the volume (VI). The auxiliary winding (WA) is electrically coupled to the main winding (WM) and arranged so that these respective windings produce respective magnetic fields of similar orientation in response to a drive signal. The antenna assembly (AA) can be disposed in a storage space (SP) that is delimited by walls of electrically conductive material, such as, for example, a metal cabinet. The antenna assembly (AA) allows reliable RFID operation within the storage space (SP). The volume (VI) over which the main winding (WM) extends is preferably only 2 to 20% smaller than that of the storage space (SP). | 10-28-2010 |
Erik Gout, Cp Weesp NL
Patent application number | Description | Published |
---|---|---|
20080286258 | Bifeprunox mesylate maintenance dose compositions and methods for using the same - The present disclosure provides novel pharmaceutical dosage forms such as a maintenance treatment dose and methods for making the same, and methods for using said compounds and maintenance treatment doses to treat and prevent diseases and/or disorders. | 11-20-2008 |
Erik Gout, Weesp NL
Patent application number | Description | Published |
---|---|---|
20110200687 | BIFEPRUNOX MESYLATE MAINTENANCE DOSE COMPOSITIONS AND METHODS FOR USING THE SAME - The present disclosure provides novel pharmaceutical dosage forms such as a maintenance treatment dose and methods for making the same, and methods for using said compounds and maintenance treatment doses to treat and prevent diseases and/or disorders. | 08-18-2011 |
Ivan Gout, London GB
Patent application number | Description | Published |
---|---|---|
20090181003 | Regulation of S6 Kinsase Protein Activity and Related Methods - The invention encompasses agents and their methods of use for modulating the activity of kinases by effecting their acetylation or their binding to nucleic acids. The invention thus encompasses the modulation of S6 kinase by effecting its acetylation by p300. The invention further encompasses the modulation of S6 kinase 2 by affecting its binding to DNA. | 07-16-2009 |
20100247542 | TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (MTOR) PROTEIN - The invention relates to mTORbeta, a splice form of mTOR, nucleic acids encoding mTOR beta, and antibodies against mTOR beta. The invention also relates to methods of producing mTOR beta and methods of screening for an agent that modulates mTOR beta expression and/or activity. The invention further relates to a method of treating a disease associated with aberrant expression of mTOR beta by administration of an agent that alters mTOR activity and/or expression. | 09-30-2010 |
20110129483 | Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy - The present disclosure relates generally to the membrane transporter NaPi2b (SLC34A2) as a target for therapy, including immunotherapy, and particularly cancer therapy. The SLC34A2 epitope peptide encompassing amino acids 312-340 of SLC34A2 has been identified as an ovarian cancer epitope using the monoclonal antibody MX35. The invention also relates to the use of SLC34A2 and particularly SLC34A2 peptides in generating antibodies which have anti-tumor or anti-cancer activity or in stimulating an immunological response. The invention further relates to antibodies specifically directed against NaPi2b (SLC34A2) and the SLC34A2 peptide (s), including veneered, chimeric, single chain and humanized antibodies. Methods for generating an immune response and for treatment of tumors and cancer are also provided. Assays for screening and identifying compounds directed against SLC34A2, including the SLC34A2 epitope peptide, and additional antibodies are provided. | 06-02-2011 |
20140120099 | TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEIN - The invention relates to mTORbeta, a splice form of mTOR, nucleic acids encoding mTOR beta, and antibodies against mTOR beta. The invention also relates to methods of producing mTOR beta and methods of screening for an agent that modulates mTOR beta expression and/or activity. The invention further relates to a method of treating a disease associated with aberrant expression of mTOR beta by administration of an agent that alters mTOR activity and/or expression. | 05-01-2014 |
20140193417 | Membrane Transporter NaPi2b (SCL34A2) Epitope for Antibody Therapy, Antibodies Directed Thereto, and Target for Cancer Therapy - The present disclosure relates generally to the membrane transporter NaPi2b (SLC34A2) as a target for therapy, including immunotherapy, and particularly cancer therapy. The SLC34A2 epitope peptide encompassing amino acids 312-340 of SLC34A2 has been identified as an ovarian cancer epitope using the monoclonal antibody MX35. The invention also relates to the use of SLC34A2 and particularly SLC34A2 peptides in generating antibodies which have anti-tumor or anti-cancer activity or in stimulating an immunological response. The invention further relates to antibodies specifically directed against NaPi2b (SLC34A2) and the SLC34A2 peptide(s), including veneered, chimeric, single chain and humanized antibodies. Methods for generating an immune response and for treatment of tumors and cancer are also provided. Assays for screening and identifying compounds directed against SLC34A2, including the SLC34A2 epitope peptide, and additional antibodies are provided. | 07-10-2014 |
Jerome Gout, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20130311829 | PERFORMANCE TESTING OF WEB COMPONENTS USING IDENTITY INFORMATION - Performance testing of web components using identity information includes providing a web component for testing having business logic code and an associated authorization layer code, locating, using a processor, branches in the authorization layer code and the business logic code which are dependent on identity information, and creating, using the processor, symbolic identities with claims or attributes having values corresponding to the branch options of the located branches. The method also includes propagating the symbolic identities downstream from the branch locations through the authorization layer code and the business logic code and analyzing, using the processor, the performance of each symbolic identity. | 11-21-2013 |
Martin Gout, Stellendam NL
Patent application number | Description | Published |
---|---|---|
20090275777 | Carboxylic Acid Production Process Employing Solvent from Esterification of Lignocellulosic Material - Methods and apparatus for producing a carboxylic acid employing a solvent from esterification of lignocellulosic materials. An acid-containing composition from esterification of lignocellulosic materials can be employed in the oxidation of para-xylene to terephthalic acid. The acid-containing composition can comprise acetic acid, acetic anhydride, and one or more terpenes. | 11-05-2009 |
Oliver Gout, Cugnaux FR
Patent application number | Description | Published |
---|---|---|
20080250852 | ELECTRONIC UNIT FOR MEASURING OPERATING PARAMETERS OF A VEHICLE WHEEL - An electronic unit for measuring operating parameters of a vehicle wheel, including an electronic module ( | 10-16-2008 |